Valuation
- Market cap
- 1,020,000
- Revenue TTM
- $300,000
- Net income TTM
- $-8,220,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -2,740.00%
- Debt to equity
- 0.00
Trading
- Volume
- 13,900
- Avg volume
- 1,321,690
- Day's range
- $1.31 – $1.41
- Shares out
- 734,000
- Stochastic %K
- 22%
- Beta
- 4.31
- Analysts
- Moderate Buy
- Price target
- $15.00
Company profile
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 heads...
Show more
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 832 260 0222
- Website
- https://www.nexalin.com
- Address
- 1776 Yorktown, Suite 550, Houston, United States
Latest news
No headlines yet.